Celltrion Secures U.S. Manufacturing Base, Paving Way for Big Pharma Leap 송영두 2025.08.14 오후 02:55 Celltrion’s Yuflyma Hits 24% in Europe on Direct Sales Strength 김새미 2025.08.04 오전 10:33 Celltrion, Tapped for API Facility Buy 김진수 2025.07.29 오전 10:49 Celltrion Nears $500M U.S. Plant Deal to Bypass Tariffs 송영두 2025.07.29 오후 01:17 Celltrion Posts Record Q2 Results, Accelerates Global Pharma Ambitions 나은경 2025.07.24 오전 10:58 Celltrion Posts Record-High Q2 Earnings with 235% Surge in Operating Profit 송영두 2025.07.21 오전 10:03 AI Diagnostics Poised to Elevate K-Bio’s Global Standing 류성 2025.07.15 오전 07:40 Celltrion to Buy Back ￦100B More, 2024 Total Hits ￦650B 김새미 2025.06.26 오전 10:25 Celltrion biosimilars expand dominance in Japan’s oncology market 임정요 2025.06.13 오전 10:11 The Achilles’ Heel of Korea’s Biopharma Giants[Yoo Sung’s Pharma National Wealth Theory] 류성 2025.05.15 오전 06:24 더 보기 로딩중..
Celltrion
Celltrion
![The Achilles’ Heel of Korea’s Biopharma Giants[Yoo Sung’s Pharma National Wealth Theory]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/05/PS25051500174b.jpg)